Bavarian Nordic A/S 2019 SR
The report highlights Bavarian Nordic's transition into a commercial vaccine company following the acquisition of two commercial vaccines and the FDA approval of its smallpox and monkeypox vaccine. The company focused on expanding its manufacturing capabilities with a new fill and finish facility in Denmark, which contributed to increased energy and water consumption during construction. Despite this, CO2 emissions decreased due to a higher share of green energy in purchased electricity. The company also improved its waste recycling rate to 50% and maintained an equal gender distribution in management positions.
Company: Bavarian Nordic A/S
Sector: Manufacturing
Country: Denmark
Year: 2019
Type: SR
Pages: 20
Back to company
Bavarian Nordic A/S
CSR Report
The report highlights Bavarian Nordic's transition into a commercial vaccine company following the acquisition of two commercial vaccines and the FDA approval of its smallpox and monkeypox vaccine. The company focused on expanding its manufacturing capabilities with a new fill and finish facility in Denmark, which contributed to increased energy and water consumption during construction. Despite this, CO2 emissions decreased due to a higher share of green energy in purchased electricity. The company also improved its waste recycling rate to 50% and maintained an equal gender distribution in management positions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Published
Feb 20, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees